What is the recommended dosage of methocarbamol (muscle relaxant) for treating muscle spasms?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 2, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Methocarbamol 750mg Dosage for Muscle Spasms

For adults with acute muscle spasms, the recommended dosage of methocarbamol 750mg is 2 tablets four times daily (6 grams/day) for the first 48-72 hours, then reduced to 1 tablet every 4 hours or 2 tablets three times daily (approximately 4 grams/day) for maintenance. 1

Initial Dosing Phase (First 48-72 Hours)

  • Start with 1500mg (2 tablets of 750mg) four times daily, totaling 6 grams per day 1
  • For severe conditions, up to 8 grams daily may be administered during this initial period 1
  • This aggressive initial dosing targets the acute inflammatory and spasm phase when symptoms are most severe 2

Maintenance Dosing (After 72 Hours)

  • Reduce to 750mg (1 tablet) every 4 hours OR 1500mg (2 tablets) three times daily, totaling approximately 4 grams per day 1
  • Continue maintenance dosing only as long as muscle spasm persists 3

Treatment Duration and Discontinuation

  • Discontinue methocarbamol as soon as a pain-free state is achieved 3, 2
  • Treatment should be time-limited to the acute phase; extended courses beyond acute pain are not supported by evidence 3
  • In clinical trials, 44% of patients achieved complete pain relief and discontinued treatment early (versus 18% with placebo) 2

Efficacy Considerations

  • Methocarbamol demonstrates approximately 60% effectiveness in painful muscle spasm compared to 30% with placebo 4
  • The drug shows clear superiority over placebo in improving mobility measures (fingertip-to-floor distance, Schober's test) and patient-reported outcomes 2
  • No compelling differences in efficacy exist among different skeletal muscle relaxants, though methocarbamol avoids specific safety concerns of alternatives 3

Safety Profile and Monitoring

  • Primary adverse effect is sedation, which is generally mild and may resolve with dose reduction 3, 5
  • CNS adverse effects occur but are typically well-tolerated 3
  • Side effects occur at similar rates to placebo in controlled trials 4
  • No severe adverse effects were observed in recent clinical studies 2

Important Clinical Caveats

  • Avoid combining with other CNS depressants without careful monitoring, as this increases sedation risk 3
  • The 750mg tablet formulation allows for more convenient dosing compared to 500mg tablets (which require 3 tablets four times daily initially) 1
  • Methocarbamol remains the only approved muscle relaxant in some jurisdictions after regulatory restrictions on alternatives like tetrazepam 2
  • The drug works peripherally by blocking muscular Nav 1.4 channels and decreasing isometric muscle force, rather than through purely central mechanisms 6

References

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.